Literature DB >> 30550982

Correlation of different cellular assays to analyze T cell-related cytokine profiles in vitamin D3-supplemented patients with multiple sclerosis.

Linda Rolf1, Joost Smolders2, Jody van den Ouweland3, Raymond Hupperts4, Jan Damoiseaux5.   

Abstract

Different laboratory approaches have been exploited to analyze an effect of vitamin D3 supplements on T cell cytokine profiles in multiple sclerosis, with poorly reproducible results. We assessed the correlation between intra-cellular flowcytometry analysis of CD4 T cell-enriched CD3+CD8- lymphocytes after PMA/ionomycin stimulation directly ex-vivo or after 72 h pre-stimulation with anti-CD3, and cytokine levels excreted in culture supernatants. Pre-stimulation with anti-CD3 resulted in higher proportions of cells positive for IFN-γ, IL-17 A, IL-4, IL-10 and GM-CSF (all P < 0.001), but not TNF-α. Positive correlation between approaches was highly variable, but most eminent for IFN- γ and IL-4 (R = 0.608-0.612 and R = 0.677-0.777, resp., all P < 0.001). No effect of 16-weeks vitamin D3 supplements on any outcome was found except for a decreased TNF-α concentration in culture supernatants. Choice of immune-assay is, apparently, a relevant confounder for the reproducibility of individual studies.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cytokines; Flowcytometry; Intracellular; Multiple sclerosis; Supernatants; Vitamin D

Mesh:

Substances:

Year:  2018        PMID: 30550982     DOI: 10.1016/j.molimm.2018.12.001

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  5 in total

Review 1.  Immunoregulatory effects and therapeutic potential of vitamin D in multiple sclerosis.

Authors:  Wei Zhen Yeh; Melissa Gresle; Vilija Jokubaitis; Jim Stankovich; Anneke van der Walt; Helmut Butzkueven
Journal:  Br J Pharmacol       Date:  2020-08-05       Impact factor: 8.739

2.  Reply: Hypercalcaemia rather than high dose vitamin D3 supplements could exacerbate multiple sclerosis.

Authors:  Darius Häusler; Sebastian Torke; Evelyn Peelen; Thomas Bertsch; Marija Djukic; Roland Nau; Catherine Larochelle; Scott S Zamvil; Wolfgang Brück; Martin S Weber
Journal:  Brain       Date:  2019-12-01       Impact factor: 13.501

Review 3.  High-Dose Vitamin D-Mediated Hypercalcemia as a Potential Risk Factor in Central Nervous System Demyelinating Disease.

Authors:  Darius Häusler; Sebastian Torke; Martin S Weber
Journal:  Front Immunol       Date:  2020-02-25       Impact factor: 7.561

4.  Vitamin D related genetic polymorphisms affect serological response to high-dose vitamin D supplementation in multiple sclerosis.

Authors:  Max Mimpen; Linda Rolf; Geert Poelmans; Jody van den Ouweland; Raymond Hupperts; Jan Damoiseaux; Joost Smolders
Journal:  PLoS One       Date:  2021-12-02       Impact factor: 3.240

Review 5.  Is there a window of opportunity for the therapeutic use of vitamin D in multiple sclerosis?

Authors:  Sofia Fernanda Goncalves Zorzella-Pezavento; Luiza Ayumi Nishiyama Mimura; Marina Bonifácio Denadai; William Danilo Fernandes de Souza; Thais Fernanda de Campos Fraga-Silva; Alexandrina Sartori
Journal:  Neural Regen Res       Date:  2022-09       Impact factor: 5.135

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.